Alia Therapeutics
About:
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Website: https://www.aliatherapeutics.com/
Twitter/X: alia_tx
Top Investors: BiovelocITA, Sofinnova Partners, Indaco Venture Partners, Trentino Invest Srl
Description:
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Total Funding Amount:
5.7M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Trento, Trentino-Alto Adige, Italy
Founded Date:
2018-01-01
Contact Email:
info(AT)aliatx.com
Founders:
Anna Cereseto, Antonio Casini, Gianluca Petris
Number of Employees:
1-10
Last Funding Date:
2023-04-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai